Aloe vera contains two pharmacologically distinct components: the inner gel (acemannan — immunostimulant and wound healer) and the outer latex (anthraquinones — potent laxatives). Our research shows topical aloe genuinely accelerates burn wound healing (meta-analysis: 9 days faster), but oral supplementation has limited evidence. The CRITICAL safety concern: aloe latex (containing aloin/emodin) was reclassified by the FDA in 2002 as "not generally recognized as safe" for oral laxative use due to concerns about colon cancer risk in animal studies. Many "aloe vera juice" products contain aloin. The inner gel (decolorized, aloin-free) is the safe form.
Two distinct pharmacological profiles: (1) Inner gel: acemannan (β-1,4-acetylated mannan) activates macrophages via mannose receptor binding, stimulating IL-1, IL-6, TNF-α, and NO production. For wound healing, acemannan increases fibroblast proliferation and collagen synthesis. For blood sugar, aloe gel polysaccharides may improve insulin sensitivity and slow glucose absorption. (2) Outer latex: anthraquinones (aloin, aloe-emodin) stimulate colonic motility by inhibiting Na+/K+ ATPase in colonocytes, causing water and electrolyte secretion into the lumen — potent stimulant laxative effect. The anthraquinones are also the source of carcinogenicity concerns.
Reviewed by the Scan Dose Research Team and Clinical Advisory Board | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.